摘要
我国胃癌在各种恶性肿瘤中居首位,年平均死亡率为25.53/10万。手术及化疗成为胃癌治疗的首选及基本治疗手段。化疗时机的选择与术后治疗效果存在差异。现将我院进展期胃癌50例术中化疗效果报道如下。
出处
《中华实验外科杂志》
CAS
CSCD
北大核心
2007年第7期863-863,共1页
Chinese Journal of Experimental Surgery
参考文献7
-
1吴在德.外科学(第6版)[M].北京:人民卫生出版社,2000.689.
-
2徐光伟.我国胃癌防治研究的回顾与展望[J].中华肿瘤杂志,1990,12(2):152-157. 被引量:17
-
3Tanaka,Tsutomu W, Kiyotakao,et al. Peri- neutal invasion as a predictor of recurrence of gastric cancer. Cancer, 1994,73 : 550.
-
4杨秋蒙,朱正纲,燕敏,李树发,薛建元,尹浩然,林言箴,金晓龙.胃肠道癌术中腹腔内温热化疗临床适应证的探讨[J].外科理论与实践,1998,3(1):11-13. 被引量:19
-
5李琛.腹腔温热化疗的临床意义及其对机体生理功能的影响[J].外科理论与实践,1998,3(1):48-51. 被引量:27
-
6Fujimoto S, Takahashi M, Muton T, et al. Successful intaperitoneal Hyperthermic chemoperfussion for the prevention of post operative peritoneal recurrence in patients with advanced gastric cancer. Cancer, 1999, 85:529.
-
7Fujimura T, Yonemura Y, Muraoka K,et al. Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer :randominzed cotrolly study. World J Surg, 1994,18 : 150.
二级参考文献28
-
1陈军,尹浩然,林言箴.进展期胃癌术后早期表阿霉素腹腔内化疗(附18例报告)[J].普外临床,1995,10(2):76-78. 被引量:9
-
2朱正纲,尹浩然,林言箴.胃肠道癌术后腹腔内温热灌注疗法的临床意义[J].普外临床,1995,10(2):73-75. 被引量:15
-
3朱正纲,朱寿柱,尹浩然,林言箴.腹腔内温热灌注疗法在防治胃癌术后腹膜复发中的临床意义[J].中国实用外科杂志,1995,15(12):710-712. 被引量:58
-
4杨秋蒙.胃癌术中腹腔内温热灌注化疗的临床应用[J].上海医学,1996,19(6):366-370. 被引量:3
-
5黄文清,神经肿瘤病理学,1982年
-
6Koga S, Hamazoe R, Maeta M, et al. Prophylactic therapy for peritoneal recurrence of gastric cancerm by continuous hyperthermic peritoneal perfusion with mitomycin C, Cancer. 1988, 61: 232.
-
7Kaibara N,Hamazoe R,Iitsuta Y,et al. Hyperthermic peritoneal perfusion combined with anticancer chemotherapy as prophylactic treatment of peritoneal recurrence of gastric cancer. Hepatogastroenterology, 1989, 36: 75.
-
8Elias D, Detroz B, Debaene B, et al. Treatment of peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: Reliable and unreliable concepts. Hepatogastroenterelogy, 1994, 41: 207.
-
9van Bree C, Krooshoop JJ, Rietbroek RC, et al.Hypertheria enhances tumor uptake and antitumor efficacy of thermostable liposomal daunorubicin in a rat solid tumor. Cancer Res,1996,56:563.
-
10Sugarbaker PH, Jablonski KA. Prognosis features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann Surg, 1995, 221: 124.
共引文献54
-
1时明龙.羟基喜树碱与ECF方案术前化疗对中、晚期胃癌近期疗效观察[J].疑难病杂志,2002,1(3):154-155. 被引量:3
-
2田艳萍.晚期胃肠道恶性肿瘤腹腔内温热化疗观察[J].肿瘤学杂志,2004,10(4):258-259. 被引量:1
-
3田禾菁,刘秀梅.中国粮食中杂色曲霉素污染状况调查及分析[J].卫生研究,2004,33(5):606-608. 被引量:8
-
4李加,李建新,陈春雷,何琳,项光泽,车斯尧.胃底贲门癌术后腹腔温热灌注化疗效果观察[J].医师进修杂志(外科版),2005,28(2):17-18. 被引量:1
-
5宋明霞.晚期胃癌DDP加艾恒双途径化疗56例疗效观察[J].中国误诊学杂志,2005,5(4):717-718.
-
6王光军,张敬强,李胡屯,郭志华,李长青.贲门癌术后早期腹腔温热灌注化疗对腹腔内复发转移的影响[J].临床医药实践,2005,14(6):416-418.
-
7陆景峰,左云.腹腔温热化疗并全身化疗治疗进展期胃癌47例[J].肿瘤研究与临床,2006,18(2):125-126. 被引量:1
-
8马博,黄三雄,陈诚.术后早期腹腔热灌注化疗在进展期胃癌中应用[J].中国肿瘤,2006,15(4):276-277. 被引量:7
-
9顾泽苗,黄耿雄,张晓忠.贲门腺癌术中综合治疗对预后的影响[J].临床和实验医学杂志,2006,5(1):34-35.
-
10罗光辉,李文建,苏兴桂.腹腔温热灌洗联合术后静脉微泵及置泵区域性动脉灌注化疗综合治疗胃肠道恶性肿瘤[J].河北医学,2006,12(12):1209-1212. 被引量:1
同被引文献19
-
1Jing-Ting Jiang, Chang-Ping Wu, Lu-Jun Chen, Xiao Zheng, Department of Tumor Biological Treatment, Third Affiliated Hospital of Soochow University, Changzhou 213003, Jiangsu Province, China Yi-Bei Zhu, Jing Sun, Xue-Guang Zhang, Key Laboratory of Stem Cell of Jiangsu Province, Institute of Biotechnology, Key Laboratory of Clinical Immunology of Jiangsu Province, Soochow University, Suzhou 215123, Jiangsu Province, China Yue-Ping Shen, Wen-Xiang Wei, Department of Medicine, Soochow University, Suzhou 215123, Jiangsu Province, China Bin-Feng Lu, Department of Immunology, University of Pitts- burgh School of Medicine, Pittsburgh, PA 15261, United States.Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients[J].World Journal of Gastroenterology,2010,16(48):6155-6162. 被引量:83
-
2Li D, Qu x J, Hou KZ, et al. PI3 K/AKT is involved in bufalin-inducedapoptosis in gastric cancer cells. Anticancer Drugs ,2009,20:59-64.
-
3Fu L, Kim YA, Wang XR, et al. Perifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major com- ponents in the mTOR axis and induces autophagy. Cancer Res,2009, 69 : 8967-8976.
-
4Fei HR, Chen G, Wang JM, et al. Perifosine induces cell cycle arrest and apoptosis in human hepatocellular carcinoma cell lines by block- ade of AKT phosphorylation. Cytotechnology, 2010,62:449-460.
-
5Wang X, Yue P, Kim YA, et al. Enhancing mammalian target of rapa- mycin (mTOR)-targeted cancer therapy by preventing mTOR/raptor inhibition-initiated, mTOR,/rictor-independent Akt activation. Cancer Res ,2008,68:7409-7418.
-
6Gills JJ, Dennis PA. Perifosine:update on a novel AKT inhibitor. Curr Oneol Rep ,2009,11 : 102-110.
-
7Chiarini F, Del Sole M, Mongiorgi S, et al. The novel AKT inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P- glycoprotein expression in muhidrug-resistant human T-acute leukemi- a cells by a JNK-dependent mechanism. Leukemia, 2008,22 : 1106- 1116.
-
8David E, Sinha R, Chen J, et al. Perifosine synergistically enhances TRAIL-induced myeloma cell apoptosis via up-regulation of death re- ceptors. Clin Cancer Res,2008,14:5090-5098.
-
9Goldman ML, Land WC, Bradley EL, et al. Transcatheter therapeutic embolization in the management of massive upper gastrointestinal bleeding[ J]. Radiology, 1976,120 ( 3 ) :513-521.
-
10Shchepotin IB, Chomy V, Hanfeh J, et al. Palliative superser selective intra-art erial chemotheray for advanced nonresectable gastriccancer [ J ]. J Gastrointest Surg, 1999,3 (4) :426-431.
引证文献4
-
1石旦,沈月平,裴红蕾,郑晓,吴骏,季枚,吴昌平,蒋敬庭.细胞因子诱导的杀伤细胞治疗胃癌对其无瘤生存的影响[J].中华实验外科杂志,2012,29(3):395-397. 被引量:7
-
2王爱军,冯俊伟,王红钰,郑宝军,施华,吴肖.二氢青蒿素通过线粒体依赖性途径诱导人胃癌细胞凋亡的机制[J].中华实验外科杂志,2012,29(7):1312-1314. 被引量:3
-
3粱松,杨力,徐皓,徐泽宽.哌立福辛通过下调M2型丙酮酸激酶抑制胃癌细胞MGC803增殖[J].中华实验外科杂志,2013(4):714-717. 被引量:3
-
4陈瑞红,于红刚.中晚期胃癌介入化疗的临床研究[J].中华实验外科杂志,2015,32(3):481-482. 被引量:9
二级引证文献22
-
1徐飞鹏,许庆文,王士己凤.肽基脯氨酰顺反异构酶和钙结合蛋白S100A9在胃癌组织中的表达及意义[J].中华实验外科杂志,2013,30(2):225-226. 被引量:4
-
2单婵婵,吴昌平,蒋敬庭.抗肿瘤细胞免疫治疗肿瘤患者的疗效评价[J].现代肿瘤医学,2013,21(8):1882-1884. 被引量:4
-
3刘涛,沈杰,何凤,卢斌,项方.肿瘤细胞免疫治疗疗效影响因素研究进展[J].西部医学,2013,25(9):1433-1436. 被引量:12
-
4张克新,王智刚,王玉月,刘娟,李丹,王远,邹永祎,李翀,蒋敬庭.细胞因子诱导的杀伤细胞及上清液对肺炎克雷伯杆菌的作用[J].中华实验外科杂志,2014,31(2):344-346. 被引量:2
-
5樊清波,马军,董海霞,李印,秦建军,刘红山,秦秉玉.白细胞介素-21对人细胞因子诱导杀伤细胞的影响[J].中华实验外科杂志,2014,31(7):1524-1526. 被引量:3
-
6崔玉忠,王英亮,王盛.恶性心包积液腔内注药疗效观察[J].国际肿瘤学杂志,2014,41(8):633-634. 被引量:1
-
7陈有挺,洪志鹏,周智,欧荣文,石铮.双氢青蒿素抑制人胆管癌生长的研究[J].中华实验外科杂志,2014,31(11):2386-2388. 被引量:1
-
8许春森,黄鹤光,陈明晃,谢捷明.南瓜蛋白诱导人胰腺癌细胞凋亡的线粒体机制[J].中华实验外科杂志,2015,32(1):15-17. 被引量:2
-
9祝仲珍,王占科,傅颖媛.肿瘤患者自体外周血CIK/DC-CIK细胞培养制备技术及临床应用研究进展[J].实验与检验医学,2015,33(3):300-303. 被引量:4
-
10郭锰,魏艳霞,任佳伟,万里新.青蒿素联合顺铂对胃癌细胞增殖、凋亡及上皮间质转化的影响[J].中成药,2016,38(2):431-434. 被引量:10
-
1苗华芹,周登峰,盛修贵.子宫颈癌辅助化疗进展[J].肿瘤研究与临床,2002,14(4):282-284. 被引量:3
-
2施靖华,陈腾,赵荣华,连兆瑞.胃癌患者术后化疗时机的选择[J].实用癌症杂志,1996,11(1):43-45. 被引量:3
-
3薛蔚,曹明.晚期前列腺癌的化疗时机[J].上海医学,2011,34(7):498-499. 被引量:4
-
4赵琪.术后化疗时机的选择对老年非小细胞肺癌患者生活质量的影响[J].咸宁学院学报(医学版),2006,20(4):322-323.
-
5郝晓伟,任明华,倪少滨.转移性肾细胞癌的治疗进展[J].中华临床医师杂志(电子版),2012,6(1):120-123.
-
6李全福(综述),方伊刚(综述),金高娃(审校).乳腺癌放疗化疗时机顺序[J].国际肿瘤学杂志,2006,33(4):280-282.
-
7覃天力,翁准,段寅,李明淑.不同化疗时机对食管癌根治术后患者的影响[J].中医药临床杂志,2004,16(5):446-447. 被引量:4
-
8董建春,华祖德,孙树三,李家福.晚期卵巢癌患者实施手术和化疗时机体细胞免疫功能的变化[J].中国肿瘤临床与康复,1996,3(S1):9-11.
-
9张令晖,邓美玉.女性肺癌危险因素分析[J].临床肺科杂志,2007,12(4):392-392. 被引量:18
-
10陈洪彬,屈俐.2种化疗方案治疗恶性滋养细胞肿瘤的体会[J].实用癌症杂志,2006,21(4):424-425. 被引量:7